IP Library Granted Patent US 11,890,435
Granted Patent B2
US 11,890,435 · App. 17/127,763 · Granted Feb 6, 2024

Method and apparatus for minimizing excess drug delivery

Inventor: Ayu Takagi (Tokyo, JP)
Assignee: Terumo Corporation
A61M25/10184A61M25/1025A61M2025/105A61M2025/1052A61M2025/1056
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,890,435
App. No.
17/127,763
Filed
Dec 18, 2020
Granted
Feb 6, 2024
Kind
B2
Art Unit
3783
USPC
604/103.02
Abstract

A device and method are described for aspirating within a patient during the delivery of a drug-coated treatment device to help remove drug coating dislodged in a patient's blood. The drug treatment device can be a drug-coated balloon, a drug-coated stent, or similar devices. The device can include an occlusion balloon to help contain the dislodged drug coating and aspiration can be applied proximally, distally, or both proximally and distally of the drug coated balloon during a procedure.

Claims (30)

1. A vascular treatment system, comprising:

a guide catheter comprising an elongated tubular body and an aspiration port in fluid communication with an interior guide catheter lumen; and,

a drug-coated balloon catheter comprising a drug-coated balloon connected at a distal region of the drug-coated balloon catheter; wherein the drug-coated balloon has a distal portion on which a drug coating is disposed, and a proximal portion that has a fully inflated diameter sized to fit into and engage with the interior guide catheter lumen.

2. The vascular treatment system of claim 1 , further comprising an enlarged tubular portion connected at the distal region of the drug-coated balloon catheter.

3. The vascular treatment system of claim 2 , wherein the drug-coated balloon catheter has a first aspiration position,

where in the first aspiration position the proximal portion of the drug-coated balloon is sealingly engaged with a distal opening of the interior guide catheter lumen, and

where in the first aspiration position the enlarged tubular portion is in fluid communication with the interior guide catheter lumen and the aspiration.

4. The vascular treatment system of claim 3 , wherein the drug-coated balloon catheter has a second aspiration position where in the second aspiration position the proximal portion of the drug-coated balloon is sealingly disengaged from the distal opening of the interior guide catheter lumen, and where in the second aspiration position the enlarged tubular portion is in fluid communication with the interior guide catheter lumen and the aspiration port.

5. The vascular treatment system of claim 4 , wherein the drug-coated balloon is connected on the enlarged tubular portion.

6. The vascular treatment system of claim 1 , wherein the distal portion of the drug-coated balloon has a fully inflated diameter that is larger than the fully inflated diameter of the proximal portion.

7. The vascular treatment system of claim 1 , wherein the fully inflated diameter of the proximal portion of the drug-coated balloon is slightly greater than, equal to, or slightly smaller than the interior guide catheter lumen.

8. The vascular treatment system of claim 1 , further comprising an occlusion balloon located distal to the drug-coated balloon.

9. The vascular treatment system of claim 2 , further comprising an occlusion balloon catheter positioned through the enlarged tubular portion and having an occlusion balloon located distal to the drug-coated balloon.

10. A vascular treatment system, comprising:

a guide catheter comprising an elongated tubular body and an aspiration port in fluid communication with an interior guide catheter lumen; and,

a drug-coated balloon catheter comprising a drug-coated balloon connected at a distal region of the drug-coated balloon catheter, and an enlarged tubular portion connected at the distal region of the drug-coated catheter;

wherein the drug-coated balloon catheter has a first aspiration position where a proximal portion of the drug-coated balloon is sealingly engaged with a distal opening of the interior guide catheter lumen, and where the enlarged tubular portion is in fluid communication with the interior guide catheter lumen and the aspiration port; and,

wherein the drug-coated balloon catheter has a second aspiration position in which the proximal portion of the drug-coated balloon is sealingly disengaged from the distal opening of the interior guide catheter lumen, and where the enlarged tubular portion is in fluid communication with the interior guide catheter lumen and the aspiration port.

11. The vascular treatment system of claim 10 , wherein the drug-coated balloon has a distal portion on which a drug coating is disposed, and a proximal portion that has an inflated diameter sized to fit into and engage with the interior guide catheter lumen.

12. The vascular treatment system of claim 10 , wherein the drug-coated balloon is connected on the enlarged tubular portion.

13. The vascular treatment system of claim 10 , wherein the distal portion of the drug-coated balloon has a fully inflated diameter that is larger than a fully inflated diameter of the proximal portion.

14. The vascular treatment system of claim 13 , wherein the fully inflated diameter of the proximal portion of the drug-coated balloon is slightly greater than, equal to, or slightly smaller than the interior guide catheter lumen.

15. The vascular treatment system of claim 10 , further comprising an occlusion balloon located distal to the drug-coated balloon.

16. The vascular treatment system of claim 10 , further comprising an occlusion balloon catheter positioned through the enlarged tubular portion and having an occlusion balloon located distal to the drug-coated balloon.

17. The vascular treatment system of claim 16 , wherein the enlarged tubular portion is about 0.050 inches.

18. The vascular treatment system of claim 10 , wherein the drug-coated balloon has pores that release a liquid drug when the drug-coated balloon is inflated.

19. A vascular treatment system, comprising:

a guide catheter; and,

a drug-coated balloon catheter means for sealingly engaging a drug-coated balloon with a distal opening of an interior guide catheter lumen of the guide catheter in a first aspiration position, where in the first aspiration position the guide catheter is in fluid communication with a first space distal to the drug-coated balloon; and,

wherein the drug-coated balloon catheter further comprises means for sealingly disengaging from the distal opening of the interior guide catheter lumen in a second aspiration position, where in the second aspiration position the guide catheter is in fluid communication with a second space proximal to the drug coated balloon.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2021
From: TAKAGI, AYU
To: TERUMO CORPORATION
Reel/Frame 056214/0643 →
Continuity (2)
Provisional Application 62950039 · Dec 18, 2019
Related Publication 20210187256A1 · Jun 24, 2021
Cited By (5)
US 12,403,296 US 12,478,775 US 12,576,263 US 12,589,237 US 12,599,749